ArticleArchives of gynecology and obstetrics2019

MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin.

Dominik Bieg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.